NAMPT and melanoma: Although experimental data in melanoma to our knowledge are currently missing, in hepatocarcinoma, pancreatic cancer, and multiple myeloma models pharmacological inhibition of NAMPT results in an inhibition of mTORC1 activity [213,318,319].